DE69119700D1 - Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren - Google Patents

Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren

Info

Publication number
DE69119700D1
DE69119700D1 DE69119700T DE69119700T DE69119700D1 DE 69119700 D1 DE69119700 D1 DE 69119700D1 DE 69119700 T DE69119700 T DE 69119700T DE 69119700 T DE69119700 T DE 69119700T DE 69119700 D1 DE69119700 D1 DE 69119700D1
Authority
DE
Germany
Prior art keywords
group
chem
formula
carbon atoms
stands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69119700T
Other languages
English (en)
Other versions
DE69119700T2 (de
Inventor
Bruce J Dezube
Arthur B Pardee
Ruth M Ruprecht
William J Novick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of DE69119700D1 publication Critical patent/DE69119700D1/de
Application granted granted Critical
Publication of DE69119700T2 publication Critical patent/DE69119700T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69119700T 1990-11-07 1991-10-28 Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren Expired - Fee Related DE69119700T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61023090A 1990-11-07 1990-11-07

Publications (2)

Publication Number Publication Date
DE69119700D1 true DE69119700D1 (de) 1996-06-27
DE69119700T2 DE69119700T2 (de) 1996-11-07

Family

ID=24444220

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69119700T Expired - Fee Related DE69119700T2 (de) 1990-11-07 1991-10-28 Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren

Country Status (16)

Country Link
EP (1) EP0484785B1 (de)
JP (1) JPH054922A (de)
KR (1) KR920009397A (de)
AT (1) ATE138266T1 (de)
AU (1) AU649278B2 (de)
CA (1) CA2055041A1 (de)
DE (1) DE69119700T2 (de)
DK (1) DK0484785T3 (de)
ES (1) ES2087205T3 (de)
GR (1) GR3020017T3 (de)
HU (1) HUT61468A (de)
IE (1) IE913879A1 (de)
IL (1) IL99966A0 (de)
PT (1) PT99434A (de)
TW (1) TW209169B (de)
ZA (1) ZA918801B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0557876B1 (de) * 1992-02-22 1996-12-11 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
ES2275400B1 (es) * 2005-04-20 2008-04-01 Universidad Autonoma De Madrid Uso de compuestos agonistas de la actividad tubulina desacetilasa de la proteina hdac6 en la elaboracion de composiciones farmaceuticas, dichas composiciones farmaceuticas y sus aplicaciones en el tratamiento de infecciones virales.
US20090239886A1 (en) 2008-02-29 2009-09-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
JP2013503883A (ja) 2009-09-02 2013-02-04 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
EP2611807A2 (de) 2010-09-01 2013-07-10 Concert Pharmaceuticals Inc. Polymorphe aus (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purin-2,6(3h,7h)dion
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
IN2014DN08443A (de) 2012-04-13 2015-05-08 Concert Pharmaceuticals Inc
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
CH608236A5 (de) * 1974-01-22 1978-12-29 Wuelfing J A Fa
US4663317A (en) * 1984-04-18 1987-05-05 Board Of Regents, University Of Texas System Methods and compositions for treating viral infections
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
GB8610136D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Compounds
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung

Also Published As

Publication number Publication date
TW209169B (de) 1993-07-11
HU913502D0 (en) 1992-01-28
KR920009397A (ko) 1992-06-25
EP0484785A3 (en) 1992-12-16
ES2087205T3 (es) 1996-07-16
EP0484785B1 (de) 1996-05-22
JPH054922A (ja) 1993-01-14
DK0484785T3 (da) 1996-09-23
GR3020017T3 (en) 1996-08-31
HUT61468A (en) 1993-01-28
EP0484785A2 (de) 1992-05-13
ATE138266T1 (de) 1996-06-15
AU8699891A (en) 1992-05-14
CA2055041A1 (en) 1992-05-08
AU649278B2 (en) 1994-05-19
IL99966A0 (en) 1992-08-18
PT99434A (pt) 1992-09-30
DE69119700T2 (de) 1996-11-07
IE913879A1 (en) 1992-05-20
ZA918801B (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DE69116503D1 (de) Aminoglycosid-Zusammensetzung mit wesentlich verminderter Nephrotoxizität
ES8307762A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina.
MX9203762A (es) Administracion de monoaminacridinas en estados deficientes en colinergicos-neuronales.
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
DE69406900D1 (de) Benzolsulfonamid-Derivate und Verfahren zur Herstellung
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DE69119700D1 (de) Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren
ATE161717T1 (de) Antivirale mittel
ATE113030T1 (de) Hydroxyalkancarbonsäure-derivate und deren verwendung.
DK0557876T3 (da) Anvendelse af xanthinderivater til behandling af muskelskader efter fuldstændig afbrydelse af blodcirkulationen
DE69308406D1 (de) Thiadiazol-Derivate zur Behandlung von depressiven Zuständen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee